( NYSE : PFE ) announced it would acquire Bristol - based King Pharmaceuticals , Inc. for a total cost to Pfizer of $3.6 billion in cash or $14.25 per share .
On October 12 , 2010 , Pfizer Inc .
( NYSE : PFE ) announced it would acquire Bristol - based King Pharmaceuticals , Inc. for a total cost to Pfizer Inc of $3.6 billion in cash or $14.25 per share .
On October 12 , 2010 , Pfizer Inc .